- Health tech company CardieX (CDX) subsidiary, ATCOR, has entered into a co-development and commercial partnership agreement with Andon
- Andon is one of China’s largest manufacturers of home-use medical electronic devices
- The first device will be ATCOR Pulse, targeted for commercial launch in U.S., Europe, Australia and China during the fourth quarter of 2021
- When Pulse pared with Arty, the device will provide full remote patient monitoring of a patient’s vital signs at home
- Under the agreement, Ardon will be responsible for obtaining the regulatory approvals in all target markets
- On the market this afternoon, CardieX is up 3.51 per cent and is trading for 5.9 cents per share at 3:32 pm AEST
